Skip to main content

Table 1 Selected demographic and histologic features of 103 CHL patients

From: Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols

Parameter

n (%)

Gender

 

 Male

59 (57.3%)

 Female

44 (42.7%)

Mean age

36 years (range: 13–85)

Age ≥ 45 years

28 (27%)

Ann Arbor Stage

 

 I

9 (8.7%)

 II

48 (46.6%)

 III

26 (25.2%)

 IV

20 (19.4%)

IPS

 

 < 3

83 (80.6%)

 ≥ 3

20 (19.4%)

Radiotherapy

 

 No

21 (22.6%)

 Yes

72 (77.4%)

Chemotherapy

 

 ABVD

34 (33%)

 ABVD + rituximab

2 (1.94%)

 CVPP/ABDIC

20 (19.4%)

 MOPP/ABVD

3 (2.9%)

 NOVP

44 (42.7%)

CHL Histologic Subtype:

 

 Nodular sclerosis

75 (72.8%)

 Mixed cellularity

22 (21.3%)

 Lymphocyte rich

3 (2.9%)

 Lymphocyte depleted

3 (2.9%)